Mulholland, David J <br/><br/>
Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells.  [electronic resource] 

 -  Cancer research  Apr 2012 
 - 1878-89 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-11-3132  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CD24 Antigen--physiology<br/>Enzyme Activation<br/>Epithelial-Mesenchymal Transition<br/>Humans<br/>Hyaluronan Receptors--physiology<br/>Luminescent Measurements<br/>Male<br/>Mice<br/>Mitogen-Activated Protein Kinase Kinases--antagonists & inhibitors<br/>Mitogen-Activated Protein Kinases--physiology<br/>Neoplasm Metastasis<br/>Neoplastic Stem Cells--pathology<br/>PTEN Phosphohydrolase--physiology<br/>Prostatic Neoplasms--drug therapy<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>ras Proteins--physiology